VerbaFlo.AI | $7,000,000 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Capital Rx
United States
- New York, New York
- 14/08/2023
- Unknown
- Undisclosed Amount
Capital Rx is a healthcare technology company changing the way prescription drugs are priced, and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single Ledger Model™, the industry’s first ethical framework for drug pricing. The company’s cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem in one system, empowering Capital Rx to deliver exceptional service to its commercial, Medicare, and Medicaid clients and members 24/7, 365 days a year. Together with its clients, Capital Rx is reimagining the administration of pharmacy benefits and rebuilding trust in healthcare.
- Industry Hospital & Health Care
- Website https://www.cap-rx.com/
- LinkedIn https://www.linkedin.com/company/cap-rx/about/
Related People
A. J. LoiaconoFounder
United States -
New York, New York
On a mission to develop the technology infrastructure our country requires, for the healthcare system patients deserve.
Quorus | $5,000,000 | (Mar 18, 2026)
BambooBox | $6,600,000 | (Mar 18, 2026)
iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
SEQUENTIAL | $3,500,000 | (Mar 18, 2026)
Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Tenkara | $7,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)